Monosomal karyotype in acute myeloid leukemia predicts adverse treatment outcome and associates with high functional multidrug resistance activity

American Journal of Hematology

Volumn 87, Issue 1, 2012, Pages 37-41

  Ahn, Hee Kyung ^a   Jang, Jun Ho ^a   Kim, Kihyun ^a   Kim, Hee Jin ^a   Kim, Sun Hee ^a   Jung, Chul Won ^a   Kim, Dong Hwan ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1; RHODAMINE 123; VERAPAMIL;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; DISEASE DURATION; EFFUSION; EVENT FREE SURVIVAL; FEMALE; GENETIC DISORDER; GENETIC RISK; HUMAN; HUMAN TISSUE; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; INCIDENCE; KARYOTYPE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MONOSOMY; P-GLYCOPROTEIN; PROGNOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84155167315     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22193     Document Type: Article

References (15)

1. Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: Analysis of 1, 612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322-2333.
2. Slovak ML, Kopecky KJ, Cassileth PA, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: A Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood 2000; 96: 4075-4083.
3. Breems DA, Van Putten WL, De Greef GE, et al. Monosomal karyotype in acute myeloid leukemia: A better indicator of poor prognosis than a complex karyotype. J Clin Oncol 2008; 26: 4791-4797.
4. Medeiros BC, Othus M, Fang M, et al. Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: The Southwest Oncology Group Experience. Blood 2010; 116: 2224-2228.
5. Leith CP, Kopecky KJ, Godwin J, et al. Acute myeloid leukemia in the elderly: Assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group Study. Blood 1997; 89: 3323-3329.
6. Samdani A, Vijapurkar U, Grimm MA, et al. Cytogenetics and P-glycoprotein (PGP) are independent predictors of treatment outcome in acute myeloid leukemia (AML). Leuk Res 1996; 20: 175-180.
7. Kim ST, Jung CW, Lee J, et al. Postremission therapy for acute myeloid leukemia in the first remission. Leuk Lymphoma 2007; 48: 937-943.
8. Mitelman F. ISCN (1995): International System for Human Cytogenetic Nomenclature. Basel: Karger; 1995.
9. Guerci A, Merlin JL, Missoum N, et al. Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry. Blood 1995; 85: 2147-2153.
10. Nooter K, Sonneveld P, Oostrum R, et al. Overexpression of the mdr1 gene in blast cells from patients with acute myelocytic leukemia is associated with decreased anthracycline accumulation that can be restored by cyclosporin-A. Int J Cancer 1990; 45: 263-268.
11. Kim DH, Lee NY, Kim JG, et al. Daunorubicin efflux assay in determining multidrug resistance of patients with acute myeloid leukemia. Leuk Lymphoma 2005; 46: 63-70.
12. Lee AJ, Endesfelder D, Rowan AJ, et al. Chromosomal instability confers intrinsic multidrug resistance. Cancer Res 2011; 71: 1858-1870.
13. McClelland SE, Burrell RA, Swanton C. Chromosomal instability: A composite phenotype that influences sensitivity to chemotherapy. Cell Cycle 2009; 8: 3262-3266.
14. Swanton C, Nicke B, Schuett M, et al. Chromosomal instability determines taxane response. Proc Natl Acad Sci USA 2009; 106: 8671-8676.
15. de Jonge HJ, de Bont ES, Valk PJ, et al. AML at older age: Age-related gene expression profiles reveal a paradoxical down-regulation of p16INK4A mRNA with prognostic significance. Blood 2009; 114: 2869-2877.